相似文献
1
A Bangkok surprise.
IAVI Rep. 2011 Sep-Oct;15(5):4-8.
2
HIV vaccine development--improving on natural immunity.
N Engl J Med. 2011 Sep 8;365(10):873-5. doi: 10.1056/NEJMp1107621.
3
The RV144 Thai HIV vaccine trial.
Hum Vaccin. 2010 Feb;6(2):159. Epub 2010 Feb 18.
4
Infectious disease. An enterprising time for HIV vaccine research.
Science. 2012 Sep 21;337(6101):1446. doi: 10.1126/science.337.6101.1446.
5
RV144: old vs. new.
Hum Vaccin. 2010 Feb;6(2):159-61. Epub 2010 Feb 18.
6
New center focuses on neutralizing antibodies.
IAVI Rep. 2008 Sep-Oct;12(5):15.
7
Bangkok after RV144.
IAVI Rep. 2013 Fall;17(3):4-8, 14.
8
HIV neutralizing antibodies reignite interest in vaccine.
Nat Biotechnol. 2012 Mar 7;30(3):204-5. doi: 10.1038/nbt0312-204c.
9
Antibodies: beyond neutralization.
IAVI Rep. 2010 Jan-Feb;14(1):8-12.
10
AIDS research. Novel antibody response may explain HIV vaccine success.
Science. 2011 Sep 16;333(6049):1560. doi: 10.1126/science.333.6049.1560.
引用本文的文献
1
Poxvirus vectors as HIV/AIDS vaccines in humans.
Hum Vaccin Immunother. 2012 Sep;8(9):1192-207. doi: 10.4161/hv.20778. Epub 2012 Aug 21.
2
Systems analysis of MVA-C induced immune response reveals its significance as a vaccine candidate against HIV/AIDS of clade C.
PLoS One. 2012;7(4):e35485. doi: 10.1371/journal.pone.0035485. Epub 2012 Apr 19.
Zotero 插件